Slides
Page 1
Investor Deck – Q1 FY27 Jul 21, 2026
Page 2
Certain statements in this release concerning Sagility’s future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. Sagility does not undertake to update any such statement that may have been made from time to time by or on behalf of the company. Safe Harbor
Page 3
▶ 27.3% Y-o-Y organic growth in Q1 FY27, driven by expansion within existing clients and rising contribution from FY26 new client wins ▶ Won $35.3M of steady state ACV in Q1 FY27, driven by expansion opportunities / new SOWs across 18 existing clients and 1 new logo ▶ Acquired CareSeed to strengthen our position in healthcare quality, especially for Medicare Advantage plans, thereby adding differentiated analytics and HEDIS capabilities while expanding our platform depth and mid-market reach. Added 26 new clients via CareSeed acquisition ▶ Increases in statutory minimum wages in Karnataka and Telangana, effective 22nd May 2026 and 1st June 2026 respectively Performance Highlights Revenue Adjusted EBITDA Adjusted PAT ₹ 19,635 Million US$207.8M ₹ 4,716 Million US $49.9M ₹ 2,697 Million US$28.6M YoY growth % 27.6% 15.2% in CC Margin % 24.0% Margin % 13.7% YoY growth % (Excl. CareSeed) 27.3% YoY growth % 27.9% YoY growth % 35.1% Q1 FY27 Business Insights Rewards & Recognitions Sagility India has been ranked 11th among India’s 100 Best Companies to Work For 2026 by Great Place to Work® India Recognized by ET Edge as Best Organizations for Women Major Contender – Healthcare Customer Experience Management (CXM) Intelligent Operations PEAK Matrix® Assessment 2026 Major Contender – Revenue Cycle Management (RCM) Intelligent Operations PEAK Matrix® Assessment 2026 Leader – Avasant Clinical and Care Management Business Process Transformation 2026 RadarViewTM 14.9% in CC
Page 4
KPIs Note: *Adjusted EBITDA represents EBITDA adjusted for earnouts payable under acquisition agreements (DCI, BirchAI , BroadPath & CareSeed), share-based payment awards and excludes other income (including forex gain/loss). **Adjusted PAT reflects EBITDA adjustments and adjustments for amortization of intangible assets arising from the carve-out of the healthcare business from HGS, as well as the statutory impact of increase in Minimum wages in Karnataka & Telangana, net of tax ^Voluntary attrition is calculated for employees with tenure exceeding 90 days and presented on an annualized basis, derived from voluntary exits during the respective quarter Q1 FY27 Q4 FY26 Q1 FY26 YoY% TTM Jun’26 TTM Jun’25 YoY% Revenue from Operation (in ₹ M) 19,635 20,243 15,389 27.6% 76,174 58,855 29.4% Steady state Revenue 19,635 17,983 15,389 27.6% 71,647 57,154 25.4% Seasonal Revenue (Open Enrollment) - 2,260 - 4,527 1,701 166.2% Revenue by Vertical Split By Payer % 89.6% 90.8% 88.4% 89.9% 89.2% By Provider % 10.4% 9.2% 11.6% 10.1% 10.8% Growth in revenue from operation (%) 27.6% 29.1% 25.8% 29.4% 21.1% Adjusted EBITDA* (in ₹ M) 4,716 5,036 3,687 27.9% 19,228 15,456 24.4% Adjusted EBITDA % 24.0% 24.9% 24.0% 25.2% 26.3% Adjusted PAT** (in ₹ M) 2,697 3,069 1,997 35.1% 12,006 8,657 38.7% Adjusted PAT % 13.7% 15.2% 13.0% 15.8% 14.7% Total Number of Employees at the end of period 47,307 46,860 39,917 18.5% 47,307 39,917 18.5% Voluntary attrition rate^ (%) 28.6% 38.1% 27.6% 30.5% 27.5%
Page 5
Annual KPIs *Client groups comprise client entities together with their affiliates. **30 clients added via CareSeed acquisition – 26 new client groups, 2 common client groups, 2 affiliates of existing client groups Q1 FY27 FY26 FY25 FY24 FY23 Numbers of Client group* Active 109 82 75 44 35 Number of new client addition 27** 17 38 13 7 Delivery Sites Number of delivery sites 29 31 33 30 27 New site addition (Gross) - 4 10 4 2 TTM Jun26 FY26 FY25 FY24 FY23 Client groups contribution to revenues Top 3 Client % 60.1% 59.9% 66.2% 68.3% 72.4% Top 5 Client % 70.1% 70.4% 77.9% 79.2% 80.6% Top 10 Client % 84.1% 83.9% 90.5% 91.4% 90.7% Number of Million-dollar client groups Number of clients contributing more than US$ 20M 9 9 7 5 4 Number of clients contributing to US$ 5M - US$ 20M 8 7 6 7 7 Number of clients contributing to US$ 1M - US$ 5M 21 21 12 12 12 Number of clients contributing less than US$ 1M 71 45 50 20 12
Page 6
+ END TO END QUALITY OF CARE PLATFORM
Page 7
Sagility-CareSeed A unified end-to-end quality operations continuum ~$5.1MN CY25 Revenue ~95% Recurring Revenue 31.4% CY25 EBITDA Margin 30 Small & mid payer clients 14 Team members CareSeed, founded in 2012 and headquartered in Kansas City, Missouri, is a U.S.-based healthcare analytics company. CareSeed solutions include Forecast, which provides HEDIS reporting and quality analytics, and Harvest, which delivers cloud-based medical record review, chart abstraction, and supplemental data capture capabilities. By combining CareSeed’s technology with Sagility’s healthcare operations, clinical services, and AI-led transformation capabilities, Sagility will deliver an end-to-end quality operations continuum. + Capability Strengthens Sagility's position in Quality for Medicare Advantage (MA) - expanding capabilities across HEDIS, CMS Stars, quality reporting, and care-gap orchestration. Technology NCQA-certified Forecast and Harvest platforms advance Sagility's shift from retrospective HEDIS reporting to AI-led, integrated quality operations. Cross-sell Expands market reach with 26 new small & mid- sized health plans plus 2 subsidiaries of existing clients - creating immediate cross-sell and greater wallet share via an integrated, tech-led BPaaS model. Talent Specialized talent strengthens capabilities across quality technology, and client management - backed by strong, established health-plan relationships.
Page 8
Sagility–CareSeed: End-to-End Quality Operations Continuum Quality of care impact analysis Abstraction management HEDIS encounter audit & validation Care Gap Closure Care Gap identification & Prioritization Population health program Provider success enablement CareSeed Technology and Analytics Sagility Technology and Analytics Analytics AI Enabled Workflow ComplianceServices 360° QUALITY OF CARE Equipping Health plans to move beyond HEDIS reporting to member-level orchestration, while unlocking STAR improvement and revenue uplift • HEDIS File Submission • Star measurement & audit tracking • RN Abstraction & Scalable Outreach (Onshore/Offshore/Digital) + Care Coordination • Robust Operational oversight • Behavior change framework driving long term health adoption • Coding validation with provider • Forecast • Care Gap/ Population health/ AIP platform • Harvest • Gap identification- Careseed core expertise • Risk stratified chase list creation
Page 9
Thought Leadership
Page 10
Future Proofing Payer Operations By the Numbers • 50 payer leaders surveyed • 94% expect AI + human oversight • 84% report limited AI value today Sagility engaged Everest Group to conduct focused research on the payer market trends and factors influencing partnership choices across 50 decision makers in the payer organizations. Independent research validates the healthcare market trends driving demand for Sagility’s AI and domain-led healthcare operations model. Key Finding What It Means Payers face mounting cost, workforce, and regulatory pressures Redesigning workflows before agentic implementation a necessity for meaningful impact70% have adopted AI; only 10% report measurable improvement 70% identify domain-led intelligent operations as a priority Deep domain knowledge is required for workflow designHealthcare expertise remains the vital foundation for payers Payer expectations are shifting toward strategic partners Understanding of the complete payer ecosystem and willingness to commit to outcomes become key criteria in partner decisions.
Page 11
Financial Highlights
Page 12
Financial Highlights Q1 FY27 delivered strong growth at steady margins, and strong cash generation - a strong start to the year ₹ 19,635 Million YoY growth % (Excl. CareSeed) 27.3% 14.9% in CC YoY growth % 27.6% 15.2% in CC ₹ 4,716 Million Margin % 24.0% YoY Growth % 27.9% YoY Growth % 35.1% Margin % 13.7% ₹ 2,697 Million ₹ 3,161 Million Conversion % 69.9% DSO 80 days
Page 13
$180.4 $189.4 $196.8 $197.3 $207.8 $25.2 $24.8 24.0% 26.2% 26.0% 24.9% 24.0% 15.0% 17.0% 19.0% 21.0% 23.0% 25.0% 27.0% 29.0% 31.0% 33.0% 35.0% $0.0 $50.0 $100.0 $150.0 $200.0 $250.0 Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27 Adjusted EBITDA Margin % Revenue ($M) Steady State Revenue ($M) Seasonal Revenue ($M) Adjusted EBITDA Margin $146.6 $157.9 $162.3 $171.5 $180.4 $9.7 $10.3 23.8% 26.1% 28.4% 26.6% 24.0% 15.0% 17.0% 19.0% 21.0% 23.0% 25.0% 27.0% 29.0% 31.0% 33.0% 35.0% $0.0 $50.0 $100.0 $150.0 $200.0 Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 Adjusted EBITDA Margin % Revenue ($M) Revenue Mix and Adjusted EBITDA Margin % Quarterly Seasonality Our Revenues exhibit seasonality. Q3 & Q4 have seasonal Revenues from Open Enrolment and AEP 2 months of BroadPath Revenue ($8.9M) Includes CareSeed effective 11th Jun’26 ($0.4M) Includes 3 month of BroadPath revenue ($11.3M) $172.0 $181.8 $222.0 $222.1
Page 14
Long Term Financial Performance Snapshot 14 Revenue (₹M) (growth % Y-o-Y) FY25 FY26 17.2% 29.1% Adj. EBITDA* (₹M) (growth % Y-o-Y) FY25 FY26 28.4% 23.9% Adj. PAT(₹M) (growth % Y-o-Y) FY25 FY26 37.5% 39.5% Revenue ($M) (growth % Y-o-Y) FY25 FY26 14.9% 23.6% Adj. EBITDA* ($M) (growth % Y-o-Y) FY25 FY26 25.9% 18.7% Adj. PAT ($M) (growth % Y-o-Y) FY25 FY26 34.8% 33.5% *Adjusted EBITDA represents EBITDA adjusted for earnouts payable under the acquisition agreements (DCI, BirchAI, BroadPath, & CareSeed), share-based payment awards and exclude other income (including forex gain/loss). Stronger adjusted PAT supported by lower finance cost ₹47,536 ₹55,699 ₹71,929 ₹76,174 FY24 FY25 FY26 TTM Jun26 ₹11,436 ₹14,685 ₹18,200 ₹19,228 FY24 FY25 FY26 TTM Jun26 ₹5,896 ₹8,107 ₹11,306 ₹12,006 FY24 FY25 FY26 TTM Jun26 $572.9 $658.3 $814.0 $841.3 FY24 FY25 FY26 TTM Jun26 $137.8 $173.6 $206.0 $212.6 FY24 FY25 FY26 TTM Jun26 $71.1 $95.8 $127.9 $133.1 FY24 FY25 FY26 TTM Jun26
Page 15
Other Financial Indicators 15Adjusted EPS is Adjusted PAT divided by weighted average number of equity shares Adjusted ROCE is Adjusted PAT plus Interest cost divided by capital employed (Assets excluding goodwill and intangibles assets less current liabilities) Net Debt is Borrowing plus lease liabilities less Cash and Cash equivalent including investment in Mutual Fund and Deposits . Borrowing doesn’t include accrued interest Q1 FY27 Cash Conversion at 69.9% impacted by acquisition-related earnout payments 87.2% 89.7% 64.7% 69.9%70.8% 80.5% 54.4% 53.4% FY24 FY25 FY26 Q1 FY27 Cash Conversion (%) OCF % FCF % 1.38 1.76 2.42 2.56 FY24 FY25 FY26 TTM Jun26 Adjusted EPS (in ₹) ₹21,678 ₹10,433 ₹1,962 ₹1,110 ₹0 ₹5,000 ₹10,000 ₹15,000 ₹20,000 ₹25,000 ₹30,000 FY24 FY25 FY26 TTM Jun26 Net Debt Net Debt (in ₹ Million) 1.90x 0.71x 0.11x 0.06x 47.0% 54.9% 58.9% 58.6% FY24 FY25 FY26 TTM Jun26 Adjusted ROCE %
Page 16
Particulars Q1 FY27 Q4 FY26 Q1 FY26 YoY% QoQ% Revenue from Operation 19,635 20,243 15,389 27.6% -3.0% Steady state Revenue 19,635 17,983 15,389 27.6% 9.2% Seasonal Revenue (Open Enrollment) - 2,260 - - - Employee benefits expense* 12,154 12,580 9,646 Minimum Wage impact 70 - - Other expenses^ 2,694 2,627 2,056 Adjusted EBITDA** 4,716 5,036 3,687 27.9% -6.4% Adjusted EBITDA % 24.0% 24.9% 24.0% Adjustments: M&A Earnouts -8 150 155 SAR (stock appreciation right) – Non Cash 60 39 71 Other Income^^ 143 82 50 Forex Gain / (Loss) -283 166 49 Reported EBITDA 4,525 5,094 3,560 27.1% -11.2% Finance costs 219 221 274 Depreciation and amortisation 1,280 1,242 1,182 Profit Before exceptional item 3,026 3,632 2,104 43.8% -16.7% Statutory impact of Minimum Wage increase in Karnataka and Telangana 151 - - - - Profit Before Tax 2,875 3,632 2,104 36.6% -20.8% Tax Expenses 707 1,055 618 Reported Profit After Tax 2,168 2,577 1,486 45.9% -15.9% EPS 0.46 0.56 0.32 45.9% -15.9% Adjusted PAT 2,697 3,069 1,997 35.1% -12.1% Adjusted PAT % 13.7% 15.2% 13.0% Adjusted EPS (₹) 0.58 0.66 0.43 35.1% -12.1% Q1 FY27 Consolidated Profit and Loss Amount in ₹ M *Employee benefits expense excludes M&A earnout and SAR (shown separately under adjustments), ^ Other expenses exclude forex loss, ^^ Other income excludes forex gain. Forex Gain and Forex Loss clubbed together and shown separately. ** Adjusted EBITDA represents EBITDA adjusted for earnouts payable under the acquisition agreements (DCI, BirchAI, BroadPath & CareSeed), share-based payment awards and exclude other income (including forex gain/loss). ▶ Statutory minimum wage hikes. Q1 FY27 (~40 days impact ₹70M). Margin impact estimated at ~1.2% of revenues for FY27 ▶ Q1 FY27 Forex loss of ₹283M was driven by foreign exchange hedges. ▶ Exceptional Item: Statutory Impact of Past service costs towards Gratuity and Compensated absence.
Page 17
Adjustments on EBITDA and PAT 17 Adj EBITDA Bridge: Q1 FY27 (₹M) Adj A - Earnouts under acquisition agreements and for PAT it is adjusted for tax Adj B - Share based payment awards (non-cash expenses for the company and not tax deductible) Adj C - Amortization of intangible assets (net of tax) that got created due to carveout of healthcare business from HGS & acquisitions Adj D- Exceptional items for Q1 FY27 represents adjustment for increase in past service cost of gratuity and compensated absence on account of increase in minimum wage in K arnataka & Telangana Adj PAT Bridge: Q1 FY27 (₹M) Reported EBITDA Adj A Adj B Other income/ FX gain Adjusted EBITDA Reported PAT Adj A Adj B Adj C Adjusted PATAdj D -₹8 ₹60 ₹140 ₹4,716 ₹4,525 Reported EBITDA Adj A Adj B Other Income/Fx gain Adjusted EBITDA ₹2,168 -₹6 ₹60 ₹363 ₹113 ₹2,697 1000 1500 2000 2500 3000 3500
Page 18
Go Forward Positions Particulars FY26 FY27 FY28 FY29 FY30 FY31 FY32 Closing Debt position 5,670 - - - - - - Debt Repayment 2,350 5,670 - - - - - Interest Payment 543 287 - - - - - Share based Payment awards 122 166 74 39 - - - Earnouts Cost 475 64 95 19 - - - Intangibles Amortisation (A) 1,462 1,565 1,565 1,565 1,565 1,565 1,565 Intangibles Amortisation (B) 392 473 473 393 345 284 250 Debt to be fully repaid in current Financial year Earnout Costs: FY26 includes payouts for DCI, Birch, and BroadPath; FY27 relates to BroadPath and CareSeed; and FY28–FY29 represent CareSeed earnouts only Intangibles Amortization (A) - Amortization of intangible assets that got created due to carveout of healthcare business from HGS Intangibles Amortization (B) - Amortization for intangible assets acquired in relation to acquisitions (DCI, Birch, BroadPath and CareSeed) – Ends by FY36 Amt in ₹ M
Page 19
Balance Sheet – 30th Jun 26 Particulars Jun 26 Mar 26 Property, plant and equipment 4,609 4,624 Right-of-use assets 4,612 4,868 Goodwill 65,591 64,051 Other intangible assets 20,515 20,407 Trade receivables and unbilled 17,502 18,390 Cash and cash equivalents (including investments) 9,674 9,038 Deferred tax assets (net) 1,455 1,514 Other Assets 3,926 3,114 Total Assets 127,884 126,011 Equity 99,265 96,591 Borrowings 5,777 5,776 Lease liabilities 5,114 5,330 Trade payables 2,072 2,217 Deferred tax liabilities (net) 4,049 4,211 Other Liabilities 11,607 11,887 Total Equity & Liabilities 127,884 126,011 Amt in ₹ M
Page 20
Cash Flow – Q1 FY27 Particulars Q1 FY27 FY26 Profit before tax for the period/ year 2,875 12,389 Adjustment for Non-Operating and Non-Cash items 1,666 5,271 Adjustment for working capital (1,060) (1,895) Income taxes paid (net of refunds) (319) (3,735) Net cash flows generated from operating activities (A) - OCF 3,161 12,030 Addition to Fixed Assets (745) (1,922) Free Cash flow (FCF) 2,416 10,108 Cash paid for M&A (1,360) - Investment in Mutual fund and Fixed Deposit 562 (5,370) Others 51 185 Net cash flows (used in) investing activities (B) (1,493) (7,107) Repayment of Promoter borrowings (include Interest) (112) (2,937) Repayment of lease liabilities (include Interest) (454) (1,843) Dividend paid - (234) Net cash flows (used in) financing activities (C) (566) (5,014) Net increase/ (decrease) in cash and cash equivalents (A+B+C) 1,102 (91) Cash and cash equivalents at the beginning of the year/period 3,579 3,438 Cash and cash equivalents received as part of the CareSeed acquisition 23 - Effect of movement in exchange rates on cash and cash equivalents 3 233 Cash and cash equivalents at the end of the year/ period 4,707 3,579 Net cash flows generated from operating activities % (OCF on Reported EBITDA) 69.9% 64.7% Free Cash flow % (FCF on Reported EBITDA) 53.4% 54.4% Amt in ₹ M
Page 21
Thank you.